Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Top Companion Anim Med ; 48: 100640, 2022.
Article in English | MEDLINE | ID: mdl-35104633

ABSTRACT

Overweight and obesity contribute to a variety of disease processes and negatively affect quality of life in dogs. A considerable number of epidemiological studies performed in a variety of canine communities revealed varied prevalence, and identified associated risk factors, including neutering. Associations between excessive body weight and certain diseases, including orthopedic diseases, were also reported. However, risk factors and disease associations of overweight and obesity in a larger population of dogs seen in recent years at a single referral veterinary hospital remains undefined. The present study utilized descriptive statistics and logistic regression models to characterize prevalence, risk factors, and disease associations of excessive body weight (both overweight and obesity) in 40,038 dogs that visited the Veterinary Medical Teaching Hospital at the University of California, Davis from January 2006 to December 2015. The overall prevalence of overweight and obesity in 40,038 dogs were 21.1% (n = 8461) and 20.2% (n = 8089) respectively. Dogs that were neutered, female, and considered middle-aged or senior were at increased risk of overweight and obesity. Certain breed types, including Retriever and Spaniel, and certain disease processes, including orthopedic diseases, were also at increased risk of overweight and obesity. Overweight and obesity are prevalent problems, which can benefit from continual education to raise awareness of the scale of the problem to both the veterinary community and the general public. Structured disease surveillance plans monitoring these associated factors also help to guide further research and to better prevent overweight and obesity.


Subject(s)
Dog Diseases , Overweight , Animals , Dog Diseases/epidemiology , Dog Diseases/etiology , Dogs , Female , Hospitals, Animal , Hospitals, Teaching , Obesity/epidemiology , Obesity/veterinary , Overweight/epidemiology , Overweight/veterinary , Prevalence , Quality of Life , Risk Factors
2.
Top Companion Anim Med ; 47: 100620, 2022.
Article in English | MEDLINE | ID: mdl-34936906

ABSTRACT

Overweight and obesity are commonly diagnosed in domestic cats, and undermine cats' quality of life directly or indirectly via various disease processes known to be associated with overweight and obesity. Epidemiological studies have reported varied overall prevalence among different feline populations, and commonly identified risk factors such as neutering. However, disease associations were not consistently reported. The status of feline overweight and obesity in a referral veterinary teaching hospital in the United States remains undefined as well. The present study used descriptive statistics and logistic regression models to analyze feline medical records obtained at the Veterinary Medical Teaching Hospital at the University of California, Davis from January 2006 to December 2015 and to characterize the prevalence of overweight and obesity, risk factors, and disease associations. In 9,062 feline records analyzed, the overall prevalence of overweight (17.2%; n = 1,560) and obesity (23.8%; n = 2,160) was 41.0%. Neutered, male, and crossbred cats that were in age groups between 3.0 and 14.9 years old and presented with disease processes in orthopedic, dentistry, and urinary categories were positively associated with overweight and obesity. Overweight and obesity are prevalent problems, which can benefit from continual veterinary education emphasizing its importance. Structured disease surveillance plans monitoring these associated factors also help guide further research and ideally can contribute to development of better prevention strategies for overweight and obesity.


Subject(s)
Cat Diseases , Overweight , Animals , Cat Diseases/epidemiology , Cat Diseases/etiology , Cats , Hospitals, Animal , Hospitals, Teaching , Male , Obesity/epidemiology , Obesity/veterinary , Overweight/epidemiology , Overweight/veterinary , Prevalence , Quality of Life , Risk Factors
3.
Res Vet Sci ; 136: 416-421, 2021 May.
Article in English | MEDLINE | ID: mdl-33812284

ABSTRACT

Reliability of canine plasma amino acid analysis depends on sample stability which can be influenced by pre-analytical handling techniques, storage temperature, storage time, and deproteinization status. Extrapolating data to dogs from research in other species is limited given discordant methodology and interspecies differences. The present study investigated the effects of deproteinization status (non-deproteinized or deproteinized) and storage temperature (at -20 °C or - 80 °C) on the concentration of 22 canine plasma amino acids during a 300-day storage period. Storage time had a significant effect (p < 0.05) of overall declining concentration of most amino acids. Compared to non-deproteinized samples, deproteinization contributed to overall higher concentrations of cyst(e)ine and glutamic acid, and consistently modified the effect of storage time and temperature on cyst(e)ine, glutamic acid, and glutamine. Compared to -20 °C, storage at -80 °C contributed to a higher concentration of cyst(e)ine and glutamic acid, and modified the effect of storage time on arginine, glutamic acid, glutamine, and tryptophan. Storage time had a consistent, significant effect on amino acid concentrations in canine plasma samples. Although sample deproteinization and low storage temperature modified the effect of storage time, these interactions were variable among analyzed amino acids. Therefore, timely sample analysis is recommended. If delayed sample analysis is inevitable, deproteinization should be performed prior to sample banking to preserve amino acid stability.


Subject(s)
Amino Acids/blood , Blood Preservation/veterinary , Blood Proteins , Animals , Blood Proteins/chemistry , Dogs , Female , Male , Plasma/chemistry , Reproducibility of Results , Temperature , Time Factors
4.
Basic Res Cardiol ; 110(3): 22, 2015 May.
Article in English | MEDLINE | ID: mdl-25820907

ABSTRACT

Patients with coronary artery disease show high serum levels of interleukin (IL)-27, a novel member of the IL-6 family. However, the function of IL-27 in hearts suffering ischemia/reperfusion (IR) injury is unclear. Here, we showed increased expression of mRNA for the IL-27 subunits, EBI3 and p28, in rat hearts after 40 min of coronary ligation and release for 7 days. This increase was associated with a peak in the release of the cardiac enzyme, creatine kinase-MB, on day 2 post-release. Moreover, levels of IL-27 receptor subunit gp130 mRNA, but not those of subunit WSX-1 mRNA, decreased in post-ischemic hearts. These results suggest that increased IL-27 production may compensate for receptor downregulation during myocardial recovery. Lactate dehydrogenase release and crystal violet staining revealed that IL-27 or IL-6 significantly attenuated severe hypoxia (SH, 2 % O2)-induced cell damage in H9c2 cardiomyoblasts and primary rat neonatal cardiomyocytes. Incubating cardiomyocytes with IL-27 or IL-6 resulted in time-dependent activation of signal transducers and activators of transcription 3 (STAT3). Interestingly, IL-27-induced STAT3 activation was attenuated by pre-treatment with a gp130-neutralizing antibody. Blocking gp130 also reduced the cytoprotective effects of IL-27 or IL-6. Moreover, IL-27-mediated protection against SH was blocked by stattic, a small-molecule inhibitor of STAT3. IL-27 markedly improved post-ischemic recovery and reduced tissue damage in isolated perfused hearts when administered 5 min before reperfusion. These results indicate that IL-27 protects the myocardium against IR injury and facilitates the recovery of damaged cardiomyocytes via the gp130/STAT3 pathway.


Subject(s)
Cytokine Receptor gp130/metabolism , Interleukins/metabolism , Myocardial Reperfusion Injury/metabolism , STAT3 Transcription Factor/metabolism , Signal Transduction/physiology , Animals , Blotting, Western , Disease Models, Animal , Polymerase Chain Reaction , Rats , Rats, Wistar
5.
Int J Med Sci ; 11(5): 515-21, 2014.
Article in English | MEDLINE | ID: mdl-24688317

ABSTRACT

OBJECTIVE: This is an Asian study, which was designed to examine the correlations between biochemical data and food composition of diabetic patients in Taiwan. METHODS: One hundred and seventy Taiwanese diabetic patients were enrolled. The correlations between biochemical data and diet composition (from 24-hour recall of intake food) of these patients were explored (Spearman correlation, p < 0.05). Diet components were also correlated with each other to show diet characteristics of diabetic patients in Taiwan. Linear regression was also performed for the significantly correlated groups to estimate possible impacts from diet composition to biochemical data. RESULTS: Postprandial serum glucose level was negatively correlated with fat percentage of diet, intake amount of polyunsaturated fatty acid and fiber diet composition. Hemoglobin A1c was negatively correlated with fat diet, polyunsaturated fatty acid and vegetable diet. Fat composition, calorie percentage accounted by polyunsaturated fatty acid and monounsaturated fatty acid in diet seemed to be negatively correlated with sugar percentage of diet and positively correlated with vegetable and fiber composition of diet. Linear regression showed that intake amount of polyunsaturated fatty acid, calorie percentage accounted by polyunsaturated fatty acid, fat percentage of diet, vegetable composition of diet would predict lower hemoglobin A1c and postprandial blood sugar. Besides, higher percentage of fat diet composition could predict higher percentage of vegetable diet composition in Taiwanese diabetic patients. CONCLUSION: Fat diet might not elevate serum glucose. Vegetable diet and polyunsaturated fatty acid diet composition might be correlated with better sugar control in Taiwanese diabetic patients.


Subject(s)
Blood Glucose , Diabetes Mellitus/blood , Dietary Fats/administration & dosage , Hyperglycemia/blood , Adult , Aged , Diabetes Mellitus/diet therapy , Diabetes Mellitus/pathology , Dietary Fiber/administration & dosage , Fatty Acids, Unsaturated/administration & dosage , Female , Glycated Hemoglobin/metabolism , Humans , Male , Middle Aged , Postprandial Period , Taiwan , Vegetables/chemistry
6.
Obesity (Silver Spring) ; 17(6): 1150-7, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19247274

ABSTRACT

The aim was to examine the role of cyclooxygenase (COX)-2-mediated inflammation in the development of obese linked insulin resistance and fatty liver. The rats were fed separately regular diet (CONT), high-fat diet (HFD) ad libitum, or energy restrictedly for 12 weeks. Rats fed HFD ad libitum were further divided into three subgroups co-treated with vehicle (HFa), or a selective COX-2 inhibitor celecoxib (HFa-Cel) or mesulid (HFa-Mes). Euglycemic hyperinsulinemic clamp (EHC) experiment was performed at the end of study. Another set of rats with similar grouping was further divided into those with a 4, 8, or 12-week intervention period for hepatic sampling. Body weight was increased significantly and similarly in HFa, HFa-Cel, and HFa-Mes. Time-dependent increases in plasma insulin, glucose, 8-isoprostanes, leptin levels, homeostasis model assessment of insulin resistance (HOMA-IR) and hepatic triglyceride contents shown in HFa were significantly reversed in HFa-Cel and HFa-Mes. During EHC period, the reduction in stimulation of whole body glucose uptake, suppression of hepatic glucose production and metabolic clearance rate of insulin shown in HFa were significantly reversed in HFa-Cel and HFa-Mes. The enhanced COX-2 and tumor necrosis factor-alpha (TNF-alpha) but attenuated PPAR-gamma and C/EBP-alpha mRNA expressions in epididymal fat shown in HFa were significantly reversed in HFa-Cel and HFa-Mes. The increases in average cell size of adipocytes and CD68 positive cells shown in HFa were also significantly reversed in HFa-Cel and HFa-Mes. Our findings suggest that COX-2 activation in fat inflammation is important in the development of insulin resistance and fatty liver in high fat induced obese rats.


Subject(s)
Adipocytes/enzymology , Adipose Tissue/enzymology , Cyclooxygenase 2/metabolism , Fatty Liver/etiology , Insulin Resistance , Obesity/complications , Panniculitis/etiology , Adipocytes/drug effects , Adipocytes/pathology , Adipogenesis , Adipose Tissue/drug effects , Adipose Tissue/pathology , Animals , Blood Glucose/metabolism , Body Weight , Celecoxib , Cell Size , Cyclooxygenase 1/metabolism , Cyclooxygenase 2/genetics , Cyclooxygenase 2 Inhibitors/pharmacology , Dinoprost/analogs & derivatives , Dinoprost/blood , Disease Models, Animal , Fatty Liver/enzymology , Fatty Liver/pathology , Insulin/blood , Leptin/blood , Liver/metabolism , Liver/pathology , Macrophages/metabolism , Male , Membrane Proteins/metabolism , Obesity/enzymology , Obesity/pathology , Panniculitis/enzymology , Panniculitis/pathology , Pyrazoles/pharmacology , Rats , Rats, Sprague-Dawley , Sulfonamides/pharmacology , Time Factors , Triglycerides/metabolism , Tumor Necrosis Factor-alpha/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...